Mr. Miyashita is presently Director of Corporate Venture Investment with Eisai Co, Ltd.

Prior to this, he held roles in corporate strategy with a focus on business development as well as being stationed in Andover, MA where he was head of Portfolio Management of Andover Innovation Medicines. While at Andover, he assumed executive responsibility for drug discovery research through direct collaborations with peer laboratories involved in early-stage pharmaceutical development. Before that, he has 15 years of experience as a biologist in drug discovery research along with management roles related to strategic planning in Eisai’s laboratories. Mr. Miyashita received his MS in Molecular Biology from Gifu Pharmaceutical University.